BSE Live
Oct 03, 16:01Prev. Close
346.50
Open Price
346.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:59Prev. Close
346.45
Open Price
347.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 5.09 | 1.00 | 23.87 | 0.72 | 2.36 | |
Diluted EPS (Rs.) | 5.09 | 1.00 | 23.82 | 0.72 | 2.34 | |
Cash EPS (Rs.) | 6.14 | 2.00 | 24.70 | 1.62 | 3.20 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 95.98 | 90.88 | 90.91 | 67.40 | 65.89 | |
Book Value [InclRevalReserve]/Share (Rs.) | 95.99 | 90.89 | 90.92 | 67.41 | 65.89 | |
Dividend / Share(Rs.) | 0.50 | 0.50 | 1.50 | 0.50 | 0.00 | |
Revenue from Operations/Share (Rs.) | 18.68 | 17.72 | 16.60 | 14.48 | 16.90 | |
PBDIT/Share (Rs.) | 3.48 | 3.80 | 2.46 | 2.07 | 3.86 | |
PBIT/Share (Rs.) | 2.42 | 2.79 | 1.48 | 1.17 | 2.99 | |
PBT/Share (Rs.) | 5.50 | 1.25 | 24.75 | 1.16 | 2.99 | |
Net Profit/Share (Rs.) | 5.07 | 0.99 | 23.72 | 0.72 | 2.34 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 18.64 | 21.42 | 14.79 | 14.28 | 22.81 | |
PBIT Margin (%) | 12.94 | 15.72 | 8.93 | 8.06 | 17.70 | |
PBT Margin (%) | 29.47 | 7.06 | 149.08 | 8.03 | 17.68 | |
Net Profit Margin (%) | 27.16 | 5.60 | 142.92 | 4.95 | 13.82 | |
Return on Networth / Equity (%) | 5.28 | 1.09 | 26.09 | 1.06 | 3.54 | |
Return on Capital Employed (%) | 2.09 | 2.55 | 1.44 | 1.69 | 4.47 | |
Return on Assets (%) | 3.90 | 0.86 | 21.86 | 0.97 | 3.27 | |
Total Debt/Equity (X) | 0.25 | 0.19 | 0.12 | 0.01 | 0.00 | |
Asset Turnover Ratio (%) | 0.15 | 0.16 | 0.18 | 0.20 | 23.65 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.25 | 3.99 | 3.68 | 4.07 | 3.94 | |
Quick Ratio (X) | 0.77 | 3.03 | 2.87 | 3.15 | 3.16 | |
Inventory Turnover Ratio (X) | 2.99 | 1.69 | 1.78 | 1.88 | 4.71 | |
Dividend Payout Ratio (NP) (%) | 9.84 | 150.96 | 2.10 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 8.14 | 74.91 | 2.02 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 90.16 | -50.96 | 97.90 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 91.86 | 25.09 | 97.98 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 43,585.67 | 33,162.95 | 25,351.78 | 39,552.67 | 48,454.80 | |
EV/Net Operating Revenue (X) | 19.44 | 15.59 | 12.72 | 22.75 | 23.89 | |
EV/EBITDA (X) | 104.25 | 72.77 | 85.97 | 159.29 | 104.72 | |
MarketCap/Net Operating Revenue (X) | 18.27 | 14.91 | 12.43 | 23.11 | 24.18 | |
Retention Ratios (%) | 90.15 | -50.96 | 97.89 | 0.00 | 0.00 | |
Price/BV (X) | 3.55 | 2.91 | 2.27 | 4.96 | 6.20 | |
Price/Net Operating Revenue | 18.27 | 14.91 | 12.43 | 23.11 | 24.19 | |
Earnings Yield | 0.01 | 0.00 | 0.11 | 0.00 | 0.01 |
18.09.2025
18.09.2025
11.09.2025
05.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y